Lineage Cell Therapeutics, Inc.

LCTX

Exchange: NYSE
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0000876343

SEC filings (opens in a new tab)

No open-market purchases or sales by Lineage Cell Therapeutics, Inc. insiders were filed in the last 90 days; 131 institutions reported holding it in 13F filings for Q2 2026, worth $152.7M in total; no superinvestor holds it.

Q4 2025 vs. Q3 2025

How the institutions holding Lineage Cell Therapeutics, Inc. changed between Q3 2025 and Q4 2025.

All holders in Q4 2025 All holders in Q3 2025

13F holders of LCTX: Q3 2025 compared with Q4 2025
Measure	Q3 2025	Of which not filed for Q4 2025	Q4 2025	Change
Holders	112	2	123	+13
Shares	87.9M	84.3K	101.7M	+13.8M (+15.7%)
Value	$148.6M	$142.5K	$169.8M	+$21.3M (+14.4%)

2 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (25)

Institutions that held Lineage Cell Therapeutics, Inc. at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to LCTX in Q4 2025
Institution	Shares	Value	% of portfolio
Defender Capital, LLC.	6,829,099	$11.4M	3.70%
Marshall Wace, LLP	1,362,061	$2.27M	0.00%
Omers Administration Corp	283,200	$472.9K	0.00%
SEI Investments Co	269,311	$449.7K	0.00%
McMillan Office, Inc.	216,000	$360.7K	0.04%
Qube Research & Technologies Ltd	211,348	$353.0K	0.00%
ExodusPoint Capital Management, LP	181,694	$303.4K	0.00%
Point72 Asset Management, L.P.	159,408	$266.2K	0.00%
Lighthouse Investment Partners, LLC	84,600	$141.3K	0.00%
Hudson Bay Capital Management LP	74,447	$124.3K	0.00%
Voleon Capital Management LP	70,968	$118.5K	0.00%
Squarepoint Ops LLC	65,109	$108.7K	0.00%
XTX Topco Ltd	42,281	$70.6K	0.00%
Two Sigma Securities, LLC	23,598	$39.4K	0.01%
DLD Asset Management, LP	20,000	$33.4K	0.00%
Define Financial, LLC	20,000	$33.4K	0.02%
SG Americas Securities, LLC	14,789	$25.0K	0.00%
Schonfeld Strategic Advisors LLC	13,318	$22.2K	0.00%
Stoneridge Investment Partners LLC	12,540	$21.0K	0.01%
Thrivent Financial for Lutherans	10,000	$17.0K	0.00%
WoodTrust Financial Corp	10,000	$17.0K	0.00%
Boothbay Fund Management, LLC	10,000	$16.7K	0.00%
Group One Trading, L.P.	6,503	$10.9K	0.00%
Larson Financial Group LLC	150	$251	0.00%
International Assets Investment Management, LLC	3	$5	0.00%

Sold out (12)

Institutions that held Lineage Cell Therapeutics, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.

Institutions that sold out of LCTX in Q4 2025
Institution	Shares, Q3 2025	Value, Q3 2025
Dauntless Investment Group, LLC	1,614,100	$2.73M
Simplex Trading, LLC	28,017	$47.0K
Dimensional Fund Advisors LP	27,121	$45.8K
Citizens Financial Group Inc	15,000	$25.4K
Beacon Capital Management, LLC	15,000	$25.4K
R Squared Ltd	11,823	$20.0K
AQR Capital Management LLC	11,650	$19.7K
GWM Advisors LLC	11,500	$19.4K
EverSource Wealth Advisors, LLC	288	$487
Wealthspire Advisors, LLC	88	$149
Steward Partners Investment Advisory, LLC	11	$19
Sound Income Strategies, LLC	4	$7

Not filed for Q4 2025 yet (2)

Institutions that held Lineage Cell Therapeutics, Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding LCTX in Q3 2025 that haven't filed for Q4 2025
Institution	Shares, Q3 2025	Value, Q3 2025
Point72 Asia (Singapore) Pte. Ltd.	46,817	$79.1K
Cubist Systematic Strategies, LLC	37,485	$63.4K